Arch Therapeutics, Inc. — Form D

Arch Therapeutics, Inc. of FRAMINGHAM, MA, a company, filed a Form D exempt-offering notice with the SEC on 2022-07-19. The offering totals $4.2M, of which $4.2M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (21)

NameRoleLocation
Punit W DhillonDirectorFramingham, MA
Guy W FishDirectorFramingham, MA
Laurence W HicksDirectorFramingham, MA
Michael S AbramsExecutive OfficerSherborn, MA
Daniel M YrigoyenExecutive OfficerFramingham, MA
Richard DavisExecutive OfficerGreenville, SC
Richard E DavisExecutive OfficerFramingham, MA
James R SulatDirectorFramingham, MA
William CotterExecutive OfficerMedia, PA
Avtar DhillonDirectorSan Diego, CA
Terrence NorchiDirectorWellesley, MA
Terrence NorchiExecutive OfficerWellesley, MA
Arthur RosenthalDirectorWellesley, MA
Norchi TerrenceDirectorWellesley, MA
Norchi TerrenceExecutive OfficerWellesley, MA
Alan BarberExecutive OfficerWellesley, MA
ARTHUR W ROSENTHALDirectorCAMBRIDGE, MA
ALAN W BARBERExecutive OfficerCAMBRIDGE, MA
AVTAR W DHILLONDirectorCAMBRIDGE, MA
TERRENCE W NORCHIDirectorCAMBRIDGE, MA
TERRENCE W NORCHIExecutive OfficerCAMBRIDGE, MA

Other filings by this issuer (6)

FiledFormOfferingSold
2021-02-25D$7.5M$6.9M
2020-06-15D$2.0M$550K
2016-06-02D$3.5M$3.4M
2015-03-17D$750K$750K
2014-02-07D$2.9M$2.9M
2013-07-08D$7.3M$7.3M

More